行情

BCRX

BCRX

BioCryst制药
NASDAQ

实时行情|Nasdaq Last Sale

4.690
+0.195
+4.34%
盘前: 4.790 +0.1 +2.13% 08:30 06/02 EDT
开盘
4.490
昨收
4.495
最高
4.770
最低
4.410
成交量
729.53万
成交额
--
52周最高
6.29
52周最低
1.380
市值
7.23亿
市盈率(TTM)
-4.9614
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测BCRX价格均价为8.43,最高价位13.00,最低价为4.000。

EPS

BCRX 新闻

更多
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 23分钟前
BioCryst Announces Full Exercise of Underwriters Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire · 15小时前
65 Biggest Movers From Yesterday
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 4天前
BioCryst to Present at Jefferies Virtual Healthcare Conference
GlobeNewswire · 4天前
48 Stocks Moving In Thursday's Mid-Day Session
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares jumped 207.6% to $12.15 after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.
Benzinga · 4天前
TWTR, HPQ among premarket losers
Seeking Alpha - Article · 4天前
28 Stocks Moving in Thursday's Pre-Market Session
Gainers
Benzinga · 5天前
BioCryst Pharma Late Wed. Priced ~18.7M Share Offering At $4.50/Share
Benzinga · 5天前

所属板块

生物技术和医学研究
+0.07%
制药与医学研究
-0.77%

热门股票

代码
价格
涨跌幅

BCRX 简况

BioCryst Pharmaceuticals, Inc.是一家生物技术公司。该公司设计、优化及开发用于封锁疾病发病原相关酶的小分子药物。该公司专注于治疗罕见病。该公司运用X光散射技术、分子结构计算机模拟和化学技术集中研究控制细胞生物学的酶的三维分子结构及活性部位特征。其候选药物包括RAPIVAB、RAPIACTA、PERAMIFLU、Avoralstat、BCX7353、其他第二代遗传性血管水肿(HAE)复方药、BCX4430及Forodesine。其RAPIVAB产品含有Peramivir。Peramivir是一种经多国认证的静脉内神经氨酸苷酶抑制剂,用于治疗流感患者。Peramivir在美国被称为RAPIVAB。RAPIVAB用于治疗无并发症的急性流感。BCX4430是广谱型抗病毒(BSAV)研究计划。
展开

微牛提供BioCryst Pharmaceuticals, Inc.(NASDAQ-BCRX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BCRX股票新闻,以帮助您做出投资决策。